Tong Ren Tang Technologies Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tong Ren Tang Technologies Company Limited with three other
companies in this sector in China:
Northeast Pharmaceutical Group Co., Ltd.
sales of 4.81 billion Chinese Renmimbi [US$731.51 million]
of which 61%
was Pharmaceutical Products),
Hubei Jumpcan Pharmaceutical Co Ltd
(4.68 billion Chinese Renmimbi [US$710.93 million]
of which 96%
was Industrial Manufacturing), and
China Medical System Holdings Limited
(4.90 billion Chinese Renmimbi [US$744.83 million]
of which 100%
was Pharmaceutical Products).
Tong Ren Tang Technologies Company Limited reported sales of 4.67 billion Chinese Renmimbi (US$709.03 million)
December of 2016.
increase of 17.0%
versus 2015, when the company's sales were 3.99 billion Chinese Renmimbi.
Sales at Tong Ren Tang Technologies Company Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 141%).
Sales of All Other Segments saw an increase
that was more than double the company's growth rate: sales were up
53.4% in 2016, from
723.66 million Chinese Renmimbi to 1.11 billion Chinese Renmimbi.